SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-027595
Filing Date
2020-10-06
Accepted
2020-10-06 16:37:29
Documents
2
Period of Report
2020-09-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3100
2 EX-24 DOCUMENT attachment1.htm EX-24 4371
  Complete submission text file 0000899243-20-027595.txt   8817
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address APELLIS PHARMACEUTICALS, INC. 100 5TH AVENUE, 3RD FLOOR WALTHAM MA 02451
Business Address
Eisele Jeffrey (Reporting) CIK: 0001827326 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38276 | Film No.: 201227139